Skip to main content

Table 1 Baseline characteristics in the HIT group and the MICT groupa

From: High-intensity interval training and health-related quality of life in de novo heart transplant recipients – results from a randomized controlled trial

Variables HIT (n = 37) MICT (n = 41)
Sex n (%) men 28 (76) 29 (71)
Age (years) 50 ± 12 48 ± 14
Body Mass Index kg/m2 24.8 ± 3.4 25.6 ± 3.9
In a relationship (married/cohabitant) 22 (61) 30 (73)
Employed 8 (22) 9 (22)
Primary diagnosis n (%)
 CM/CAD/Other 21 (57) / 14 (38) / 2 (5) 31 (75) / 6 (15) / 4 (10)
 Donor age (years) 37 ± 14 39 ± 14
 Ischaemic time (min) 181 ± 77 184 ± 82
 Median (IR) years of HF duration pre HTx 4.0 (9.1) 4.5 (8.1)
 Median (IR) days on waitlist 85 (192) 71 (167)
 Smoking (n (%) No/Ex-smoker) 18 (49) / 19 (51) 21 (51) / 20 (49)
 Biomarkers
 Hemoglobin (g/dL) 11.8 ± 1.8 11.7 ± 1.6
 Creatinine (μmol/L) 116.1 ± 33.9 118.5 ± 28.0
 eGFR (mL/min/1.73m2) 65.1 ± 20.9 62.7 ± 23.3
 HbA1c (%) 5.7 ± 0.9 5.6 ± 0.7
Medication at inclusion n (%)
 Ciclosporine 24 (65) 31 (76)
 Tacrolimus 11 (30) 10 (24)
 Everolimus 12 (32) 13 (32)
 Prednisolone 37 (100) 41 (100)
 Mycophenolate 34 (92) 36 (88)
 Statin 36 (97) 41 (100)
 Beta blocker 9 (24) 12 (30)
 Calcium blocker 8 (22) 12 (30)
 ACE inhibitor 0 2 (5)
 ARB 4 (11) 3 (8)
 Diuretics 31 (84) 32 (78)
  1. Variables are presented as mean ± standard deviation, median (interquartile range (IR)) or number (percentages). ACE angiotensin converting enzyme, ARB angiotensin II reseptor blocker, CAD coronary artery disease, CM cardiomyopathy, eGFR estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration calculation), HbA1c hemoglobin A1c, HF heart failure, HIT High-intensity interval training, HTx heart transplantation, MICT moderate intensity contionuous training
  2. aNo difference between groups